e-learning
resources
Munich 2006
Sunday 03.09.2006
Therapies and management in chronic airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prospective analysis of lung function in COPD patients – home monitoring of FEV
1
and PEF (PIKO®1)
M. Guimaraes, A. Oliveira, A. Rego, N. Taveira (Porto, Portugal)
Source:
Annual Congress 2006 - Therapies and management in chronic airway diseases
Session:
Therapies and management in chronic airway diseases
Session type:
E-Posters in free access
Number:
707
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Guimaraes, A. Oliveira, A. Rego, N. Taveira (Porto, Portugal). Prospective analysis of lung function in COPD patients – home monitoring of FEV
1
and PEF (PIKO®1). Eur Respir J 2006; 28: Suppl. 50, 707
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Post-bronchodilator response (PBDR) evaluated by plethysmographic and spirometric target parameters in patients with COPD, asthma-COPD-overlap (ACO) and asthma
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018
Changes in spirometry (FVC and FEV
1
) in a closed population of COPD patients using new standarized values for Mexican people
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Analysis of the post bronchodilator forced expiratory volume in one second of COPD patients clinically followed up for three years
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Effect of umeclidinium/vilanterol (UMEC/VI) on inspiratory capacity/total lung capacity ratio in hyperinflated COPD patients
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction?
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Forced expiratory volume in one second (FEV
1
) and peak expiratory flow (PEF): is there a correlation in chronic obstructive pulmonary disease (COPD) patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 213s
Year: 2001
Forced oscillation technique (FOT) in the evaluation of COPD patients enrolled in Pulmonary Rehabilitation (PR)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients
Source: Eur Respir J 2003; 21: 21S-27S
Year: 2003
Home telemonitoring (forced expiratory volume in 1 s) in children with severe asthma does not reduce exacerbations
Source: Eur Respir J 2012; 39: 290-296
Year: 2012
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Spirometric parmameters during single examination, besides peak expiratory flow (PEF) variability, do not correlate with quality of life (QL) in children with stable asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 256s
Year: 2006
Is impulse oscillometry (IOS) better than spirometry for monitoring treatment outcomes in adult cystic fibrosis (CF) pulmonary exacerbations? A pilot study
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
FEV
6
as an alternative for FVC in detecting airflow obstruction in COPD patients undergoing six minute Walk test
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept